IPO Detail
Rubicon Research
MAINBOARDBSE, NSE · Pharmaceutical / Healthcare (Drug Development & Manufacturing)
ListedAllotment OutCheck AllotmentNot investment advice. Read RHP before applying.
Price Band
₹461 – ₹485
GMP (Indicative)
₹120
Unofficial · not guaranteed
Lot Size
30 shares
Status
Listed
Open Date
2025-10-09
Close Date
2025-10-13
Listing Date
2025-10-16
Min. Investment
₹14,550
Overview
About the Company
Rubicon Research Limited is a pharmaceutical company focused on developing and manufacturing generic drugs, specialty pharmaceutical products, and drug delivery systems. The company provides contract development and manufacturing services (CDMO) to global pharmaceutical companies and focuses on innovation in oral solid dosage forms.
New to IPO analysis? You may review our structured guides on how IPO allotment works and IPO subscription meaning to better understand demand and allocation mechanics.
Financials
Key Financial Metrics
EPS Pre IPO
—
EPS Post IPO
—
P/E Pre
—
P/E Post
—
ROCE
18.5%
Debt / Equity
0.42
PAT Margin
12.7%
Market Cap
6260
Financial figures sourced from official offer documents. Always verify with the RHP.
Issue
IPO Issue Details
Issue Price
₹461 – ₹485
Face Value
₹1
Issue Size
1377.68
Fresh Issue
500.18
Listing At
BSE,NSE
Lead Manager
JM Financial Limited
Registrar
MUFG Intime India Pvt Ltd
Lot Size
30
For category-wise quota breakdown such as QIB, HNI, and Retail allocation, refer to our IPO quota structure explanation.
Investors
Anchor Investors
Abu Dhabi Investment Authority Government Pension Fund Global HDFC Mutual Fund ICICI Prudential Mutual Fund SBI Mutual Fund Kotak Mahindra Mutual Fund
GMP (Grey Market Premium)
GMP Overview
₹120
Updated —
+24.7% over issue price
GMP is unofficial and indicative only. It does not guarantee listing price or returns.
GMP is unofficial and indicative. To understand interpretation logic and limitations, read our IPO Grey Market Guide or begin with what IPO GMP means.
Trend
GMP Trend
No GMP data yet. Updates will appear once available.
Investment
Market Lot Details
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 30 | 14550 |
| Retail (Max) | 13 | 390 | 189150 |
| sNII (Min) | — | — | — |
| bNII (Min) | — | — | — |
| sNII (Max) | 68 | 2040 | 989400 |
| bNII (Max) | — | — | — |
Investors can bid in multiples of the lot size. Final investment depends on the cutoff price.
Valuation
IPO Valuation Metrics
EPS Pre IPO
—
EPS Post IPO
—
P/E Pre
—
P/E Post
—
ROCE
18.5%
Debt/Equity
0.42
RoNW
—
PAT Margin
12.7%
Market Cap
6260
Contacts
Company & Registrar Details
Company Address: Rubicon Research Limited Rubicon House, Plot No. B-2, MIDC Industrial Area, Taloja, Raigad, Maharashtra 410208, India
Phone: +91-22-2763-4100
Email: info@rubiconresearch.com
Website: https://www.rubiconresearch.com
Registrar: MUFG Intime India Pvt Ltd
Registrar Phone: +91-22-4918-6200
Registrar Email: ipo.helpdesk@linkintime.co.in
Registrar Website: https://www.linkintime.co.in
Issue Summary
Objectives of Issue
Funding capital expenditure for manufacturing expansion Investment in subsidiaries Repayment or prepayment of borrowings General corporate purposes
Ownership
Promoter Holdings
Pre Issue
75.71%
Post Issue
59.78%
Allocation
Reservation Details
QIB
74.89
NII
14.98
RII
9.99
Employee
—
Documents
Important Links
Performance
Listing Performance
Listing Exchange
BSE,NSE
Listing Price
₹680
Listing Gain
40.20618556701031%
Qualitative Factors
Strengths & Risks
Company Strengths
Strong presence in generic pharmaceutical formulations Focus on complex drug delivery systems Global customer base Experienced management team Strong research & development capabilities
Company Risks
Dependence on regulatory approvals Exposure to pharmaceutical pricing pressure Dependence on key customers Currency fluctuation risks
Schedule
Timeline
Open Date
2025-10-09
Close Date
2025-10-13
Allotment Date
2025-10-14
Refund Date
2025-10-15
Listing Date
2025-10-16
Legal Disclaimer
Information is sourced from publicly available exchange filings and company offer documents. GMP is unofficial and indicative. IPOCraft does not provide investment advice.
Subscription
Live Subscription Details
| Day | QIB | NII | sNII (< ₹10L) | bNII (> ₹10L) | Retail | Total |
|---|---|---|---|---|---|---|
| Latest | 137.09x | 117.77x | —x | —x | 37.4x | 109.35x |
Subscription Progress
Subscription data sourced from exchange updates. Values represent times subscribed (x).
Learn how subscription categories are allocated by reading our guide on QIB, HNI and Retail IPO quota structure.
If you are tracking GMP alongside subscription demand, see our grey market premium guide for a structured comparison framework.
Application
How to Apply
UPI Method (ASBA)
Log in to your broker's app or net banking, navigate to the IPO section, select this IPO, enter lot quantity, and authorise via UPI mandate. Funds are blocked, not debited, until allotment.
ASBA via Net Banking
Log in to your bank's net banking portal, go to the IPO / ASBA section, fill in the bid details, and submit. Your bank will block the required amount automatically.
Allotment & Refund
Allotment status is typically available within 6 days of the IPO close date. Refunds for unallotted bids are credited within 2 working days post allotment.
You may also review the complete IPO allotment process explanation to understand lottery mechanics and refund timelines.
Risk Disclosure
Investments in IPOs are subject to market risks. Grey Market Premium (GMP) is unofficial and indicative only — it does not guarantee listing price or returns. Read the official offer documents (DRHP / RHP) and consult a SEBI-registered financial advisor before applying. IPOCraft does not provide investment advice.
Research Before You Apply